Have a personal or library account? Click to login
Monotherapy of experimental metabolic syndrome: I. Efficacy and safety Cover

Monotherapy of experimental metabolic syndrome: I. Efficacy and safety

Open Access
|Feb 2018

Authors

Štefan Bezek

exfastbe@savba.sk

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia

Zuzana Brnoliaková

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia

Ružena Sotníková

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia

Vladimír Knezl

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia

Ema Paulovičová

Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia

Jana Navarová

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia

Viktor Bauer

Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
DOI: https://doi.org/10.1515/intox-2017-0013 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 81 - 85
Submitted on: Sep 12, 2017
Accepted on: Oct 15, 2017
Published on: Feb 14, 2018
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Štefan Bezek, Zuzana Brnoliaková, Ružena Sotníková, Vladimír Knezl, Ema Paulovičová, Jana Navarová, Viktor Bauer, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.